In conclusion, PD-L1 is a prognostic factor for NSCLC patients with squamous cell carcinoma histology, lymph node metastasis and patients treated in an adjuvant setting. This evidence concerns the gene CD274 and metastatic malignant neoplasm in the lymph nodes.